Discovery Research Articles

  1. Your Science. Our Solutions. Together Ahead. 6/20/2025

    Guided by our purpose, “In every molecule is the possibility for better health,” we are committed to driving the success of your programs and transforming hope into health for millions worldwide.

  2. Elevating Purity: Racemizing Pharmaceutical Products In Flow Microreactors 6/18/2025

    Discover how our process development team resolved a racemization challenge by delivering a biologically active racemic mixture while maintaining compound purity.

  3. Amylin Liver NASH (AMLN) 6/18/2025

    Explore how a validated diet-induced mouse model that replicates key features of human NASH can support your preclinical research and therapeutic development.

  4. Phosphoramidite Chemistry Capabilities For Oligonucleotide Synthesis 6/18/2025

    Accelerate your research and development with high-quality, custom phosphoramidite synthesis backed by decades of proven chemistry and scalable precision.

  5. Leveraging Surface Plasmon Resonance For Characterizing Ternary Complexes 6/13/2025

    Uncover how Surface Plasmon Resonance (SPR) can be used to gain real-time, label-free insights into PROTAC binding kinetics and ternary complex formation.

  6. Accelerating Oligonucleotides Discovery And Development Programs 6/13/2025

    Leverage advanced oligonucleotide synthesis capabilities to accelerate the development of ASOs, siRNA, miRNA, and other nucleic acid-based therapeutics.

  7. In Vitro Pharmacology 6/13/2025

    Our team collaborates closely with clients to deliver tailored solutions spanning cell and protein sciences, assay development and validation, and high-throughput screening.

  8. in vitro Kill Rate Studies For Antimicrobial Screening 6/13/2025

    Utilize advanced in vitro time kill-rate studies to accurately assess antimicrobial activity, understand drug-microbe interactions, and evaluate the effectiveness of combination therapies.

  9. Preclinical Evaluation Of Vaccines And Antivirals In RSV Challenge Rodent Models 6/10/2025

    Here, we present multiple case studies utilizing clinically relevant mouse and rat models to evaluate key characteristics of potential RSV therapeutics.

  10. Preclinical Evaluation Of New Antifibrotics In NASH-Induced Fibrosis Models 6/10/2025

    Accelerate the development of antifibrotic therapies through our clinically relevant models, deep scientific expertise, and proven preclinical capabilities in this area of unmet medical need.